Nexrutine® inhibits tumorigenesis in mouse skin and induces apoptotic cell death in human squamous carcinoma A431 and human melanoma A375 cells

Carcinogenesis

Volumn 33, Issue 10, 2012, Pages 1909-1918

  Kumar, Rahul ^a   Das, Mukul ^a   Ansari, Kausar M ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; CYTOCHROME C; DIMETHYLBENZ[A]ANTHRACENE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NEXRUTINE; NITRIC OXIDE SYNTHASE; PHELLODENDRON AMURENSE EXTRACT; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CLINICAL EFFECTIVENESS; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; PRIORITY JOURNAL; SKIN CANCER; SKIN EDEMA; SQUAMOUS CELL CARCINOMA; ANIMAL; CHEMICALLY INDUCED DISORDER; HUMAN; MELANOMA; MOUSE; SKIN TUMOR; TUMOR CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HUMANS; MELANOMA; MICE; PLANT EXTRACTS; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 84867296050     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs219     Document Type: Article

References (44)

1. World Health Organization (WHO) (2011) Ultraviolet Radiation and the INTERSUN Programme. http://www.who.int/uv/faq/skincancer/en/index1. html (date last accessed).
2. Hurst, K.W. et al. (2006) The role of N-cadherin, MCAM and β3 integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol. Ther., 5, 1375-1382.
3. Surh, Y.J. (2003) Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 3, 768-780.
4. Kwon, K.H. et al. (2007) Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models. Acta Pharm. Sinic., 28, 1409-1421.
5. Kumar, A.P. et al. (2007) Akt/cAMP-responsive element binding protein/ cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine®, a Phellodendron Amurense bark extract. Clin. Cancer Res., 13, 2784-2794.
6. Mori, H. et al. (1995) Principle of the bark Phellodendron amurense to suppress the cellular immune response: effect of Phellodendron on cellular and humoral immune response. Planta Med., 61, 45-49.
7. Garcia, G.E. et al. (2006) Akt- and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine®, a Phellodendron amurense extract. Neoplasia, 8, 523-33.
8. Muralimanoharan, S.B. et al. (2009) Butanol fraction containing berberine or related compound from nexrutine® inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells. Prostate, 69, 494-504.
9. James, M.A. et al. (2011) Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis. Mol. Carcinog., 50, 1-7.
10. Ghosh, R. et al. (2010) Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management. Anticancer Res., 30, 857-865.
11. Bachmanov, A.A. et al. (2002) Food intake, water intake, and drinking spout side preference of 28 mouse strains. Behav. Genet., 32, 435-443.
12. Gupta, K.P. et al. (1992) Status of ornithine decarboxylase activity and DNA synthesis in mancozed-exposed mouse skin. Carcinogenesis, 13, 131-133.
13. Verma, A.K. et al. (1979) Correlation of the inhibition by retinoid of tumor promoter-induced mouse epidermal ornithine decorboxylase activity and skin tumor promotion. Cancer Res., 39, 419-425.
14. Chun, K.S. et al. (2003) Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis, 24, 1515-1524.
15. Yuspa, S.H. et al. (1974) Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp. Cell Res., 86, 95-105.
16. Mishra, V. et al. (2009) Effect of argemone oil and argemone alkaloid, sanguinarine on Sertoli-germ cell coculture. Toxicol. Lett., 186, 104-110.
17. Gilmore, T.D. (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene, 25, 6680-6684.
18. Zhivotovsky, B. et al. (1999) Caspases: their intracellular localization and translocation during apoptosis. Cell. Death Differ., 6, 644-651.
19. Slaga, T.J. et al. (1980) Multistage chemical carcinogenesis in mouse skin. Curr. Probl. Dermatol., 10, 193-218.
20. Fischer, S.M. et al. (1988) Phorbol ester induction of 8-lipoxygenase in inbred SENCAR (SSIN) but not C57BL/6J mice correlated with hyperplasia, edema, and oxidant generation but not ornithine decarboxylase induction. Cancer Res., 48, 658-664.
21. Chung, W.Y. et al. (2007) Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-κB. Carcinogenesis, 28, 1224-1231.
22. Nguyen-Ba, G. et al. (1999) Epigenetic events during the process of cell transformation induced by carcinogens. Oncol. Rep., 6, 925-932.
23. Surh, Y.J. et al. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res., 480-481, 243-268.
24. O'Brien, T. G. et al. (1997) Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res., 57, 2630-2637.
25. Ghosh, R. et al. (2007) Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine®. Neoplasia, 9, 893-899.
26. Kundu, J.K. et al. (2005) Chemoprevention with anti-inflammatory phytochemical breaking the relay in deregulated cellular signal transduction. Mutat. Res., 591, 123-146.
27. Tak, P.P. et al. (2001) NF-κB: a key role in inflammatory diseases. J. Clin. Invest, 107, 7-11.
28. Perkins, N.D. et al. (2006) Good cop, bad cop: the different faces of NF-kappaB. Cell. Death Differ., 13, 759-772.
29. Bell, S. et al. (2003) Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal., 15, 1-7.
30. Gilmore, T.D. et al. (2011) Inhibition of NF-κB signaling as a strategy in disease therapy. Curr. Top. Microbiol. Immunol., 349, 245-263.
31. Aggarwal, B.B. et al. (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol., 71, 1397-1421.
32. Sarfaraz, S. et al. (2008) Guggulsterone modulates MAPK and NF-κB pathways and inhibits skin tumorigenesis in SENCAR mice. Carcinogenesis, 29, 2011-2018.
33. Rodust, P.M. et al. (2009) UV-induced squamous cell carcinoma-a role for antiapoptotic signalling pathways. Br. J. Dermatol., 161, 107-115.
34. Singh, R.P. et al. (2002) Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis, 23, 499-510.
35. Igney, F.H. et al. (2002) Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer, 2, 277-288.
36. Galati, G. et al. (2000) Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metab. Drug Interact., 17, 311-350.
37. Khan, N. et al. (2007) Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis, 28, 233-239.
38. Elledge, S.J. (1996) Cell cycle checkpoints: preventing an identity crisis. Science, 274, 1664-1672.
39. Hanahan, D. et al. (2000) The hallmarks of cancer. Cell, 100, 57-70.
40. Evan, G.I. et al. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 42-48.
41. Khan, N. et al. (2008) Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis, 29, 1049-1056.
42. Reed, J.C. (1998) Bcl-2 family proteins. Oncogene, 17, 3225-3236.
43. Jurgensmeier, J.M. et al. (1998) Bax directly induces release of cytochome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA, 95, 4997-5002.
44. Cecconi, F. (1999) Apaf1 and the apoptotic machinery. Cell. Death Differ., 6, 1087-1098.